Key result
The fixed-dose combination of amlodipine, perindopril, and atorvastatin provides synergistic cardioprotective effects and improves endothelial function in patients with hypertension and dyslipidemia.
Why the study?
The review aimed to outline modern concepts and evaluate the clinical relevance, pharmacodynamics, effectiveness, and safety of a fixed-dose combination of amlodipine, perindopril, and atorvastatin in hypertensive patients.
Does the fixed triple combination of amlodipine, perindopril, and atorvastatin improve cardiovascular outcomes and safety in hypertensive patients?
Does the fixed triple combination of amlodipine, perindopril, and atorvastatin improve cardiovascular outcomes and safety in hypertensive patients?
A single-pill combination of amlodipine, perindopril, and atorvastatin provides a comprehensive and synergistic approach to managing cardiovascular risk in patients with hypertension and dyslipidemia.
Supports the utility of triple fixed-dose combinations for hypertensive patients with comorbidities; leaves open the need for.
The review outlines modern concepts of the relevance of fixed-dose combination therapy comprising angiotensin-converting enzyme inhibitor and dihydropyridine calcium channel antagonist as an antihypertensive component with the HMG-CoA reductase inhibitor when treating hypertensive patients. We have identified the realms of its possible clinical use taking into consideration the comorbidity peculiarities. In addition, we provide main features of the current drugs’ clinical pharmacodynamics and outline their role in real clinical practice. Nevertheless the emphasis was placed on the modern single-pill combination of amlodipin, atorvastatin and perindopril. We concisely report the results data collected from the large, randomized, double-blind major clinical trials regarding the effectiveness of single pill combination of amlodipine, atorvastatin and perindopril , primary focusing on their cardioprotective features and overall safety profile.
No takes yet. Share an insight, caveat, or question.
Кучмин et al. (2023) conducted a review in Arterial hypertension and dyslipidemia. Fixed-dose combination of amlodipine, perindopril, and atorvastatin was evaluated. The fixed-dose combination of amlodipine, perindopril, and atorvastatin provides synergistic cardioprotective effects and improves endothelial function in patients with hypertension and dyslipidemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: